Meet Dr. Raffaele Bernardo, the face of Valley Hospital's new LGBTQ health care all inclusive program. The new facility is in Paramus.

I am a soon-to-be 85-year-old healthy woman. I take a statin and baby aspirin (I assume because of my age) and have my ...

On Jan. 1, CMS will begin implementation of a new alternative payment system for select hospitals. The Transforming Episode Accountability Model will hold participating hospitals responsible for the ...

Antimicrobial stewardship matters, and pediatric hospitalists are important team members, experts say. Here is what to know ...

With more than 234 million major operations performed annually worldwide, Enhanced Recovery After Surgery (ERAS) protocols ...

Discover a study examining how frailty and gut microbiota influence gastrointestinal complications after robot-assisted ...

Vonvendi is a recombinant von Willebrand factor previously only approved for on-demand and perioperative use in adults with VWD and routine prophylactic use in adults with severe Type 3 VWD receiving ...

We are excited to announce that we have completed enrollment of our Phase 3 SENTRY trial and look forward to sharing top-line data from this pivotal trial in March 2026 ,” said Richard Paulson, ...

FIGO highlights critical new guidance published in the International Journal of Gynaecology and Obstetrics on preventing post ...

Gastrointestinal (GI) complications, such as postoperative ileus (POI) and intra-abdominal infections (IAI), remain a major concern after radical cystectomy for bladder cancer. Even with advances in ...

Takeda’s Vonvendi receives US FDA expanded indication approval to treat adults and children with Von Willebrand disease: Osaka, Japan Monday, September 8, 2025, 13:00 Hrs [IST] ...

VONVENDI is an infused medicine designed to replace the body's missing or dysfunctional VWF. VONVENDI has a uniquely long half-life (22.6 hours [50 IU/kg] for adults and 14.3 hours for children). In ...